AllianceBernstein’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-4,283
Closed -$42K 3151
2018
Q1
$42K Hold
4,283
﹤0.01% 2998
2017
Q4
$57K Sell
4,283
-1,934
-31% -$24.9K ﹤0.01% 2993
2017
Q3
$91K Sell
6,217
-6,318
-50% -$637K ﹤0.01% 3053
2017
Q2
$1.31M Buy
12,535
+4,680
+60% +$503K ﹤0.01% 2153
2017
Q1
$1.01M Buy
7,855
+5,588
+246% +$589K ﹤0.01% 2227
2016
Q4
$203K Hold
2,267
﹤0.01% 2889
2016
Q3
$167K Buy
2,267
+134
+6% +$9.68K ﹤0.01% 2879
2016
Q2
$142K Buy
+2,133
New +$121K ﹤0.01% 2866
2016
Q1
Sell
-2,050
Closed -$152K 2936
2015
Q4
$152K Hold
2,050
﹤0.01% 2803
2015
Q3
$142K Buy
+2,050
New +$192K ﹤0.01% 2838
2015
Q2
Sell
-1,100
Closed -$121K 3307
2015
Q1
$121K Buy
1,100
+817
+289% +$95.9K ﹤0.01% 2981
2014
Q4
$38K Sell
283
-150
-35% -$17.5K ﹤0.01% 3143
2014
Q3
$49K Sell
433
-17
-4% -$2.25K ﹤0.01% 3085
2014
Q2
$76K Buy
+450
New +$77.7K ﹤0.01% 3053

Other funds holding ARAV

AllianceBernstein's ARAV Position: Q2 2018 in Review

AllianceBernstein sold out of Aravive, Inc. Common Stock (ARAV) in Q2 2018, closing a stake of 4,283 shares — an estimated $42K sold.

AllianceBernstein first reported a position in ARAV in Q2 2014 and held it in 14 quarters. The position peaked at $1.31M in Q2 2017. 61 funds tracked by Wall St. Rank hold ARAV as of Q2 2018.

  • AllianceBernstein reported no remaining Aravive, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • AllianceBernstein sold 4,283 Aravive, Inc. Common Stock shares in Q2 2018, an estimated $42K.
  • AllianceBernstein first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 14 quarters.
  • AllianceBernstein's Aravive, Inc. Common Stock position peaked at $1.31M in Q2 2017.
  • 61 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q2 2018.

Based on AllianceBernstein's 13F filing for Q2 2018, filed 13 Aug 2018.